METHODS FOR MAKING L-GLUFOSINATE
    6.
    发明申请

    公开(公告)号:US20210395790A1

    公开(公告)日:2021-12-23

    申请号:US17464887

    申请日:2021-09-02

    申请人: BASF SE

    摘要: Methods for the production of L-glufosinate (also known as phosphinothricin or (S)-2-amino-4-(hydroxy(methyl)phosphonoyl)butanoic acid) are provided. The methods comprise a two-step process. The first step involves the oxidative deamination of D-glufosinate to PPO (2-oxo-4-(hydroxy(methyl)phosphinoyl)butyric acid). The second step involves the specific amination of PPO to L-glufosinate, using an amine group from one or more amine donors. By combining these two reactions, the proportion of L-glufosinate in a mixture of L-glufosinate and D-glufosinate can be substantially increased.

    Transaminase polypeptides
    9.
    发明授权

    公开(公告)号:US10995323B2

    公开(公告)日:2021-05-04

    申请号:US16717596

    申请日:2019-12-17

    申请人: Codexis Inc.

    IPC分类号: C12N9/10 C12P13/00 C12P41/00

    摘要: The present disclosure provides engineered transaminase enzymes having improved properties as compared to a naturally occurring wild-type transaminase enzyme. Also provided are polynucleotides encoding the engineered transaminase enzymes, host cells capable of expressing the engineered transaminase enzymes, and methods of using the engineered transaminase enzymes to synthesize a variety of chiral compounds.

    Ketoreductase polypeptides
    10.
    发明授权

    公开(公告)号:US10988739B2

    公开(公告)日:2021-04-27

    申请号:US16708109

    申请日:2019-12-09

    申请人: Codexis, Inc.

    摘要: The present disclosure provides engineered ketoreductase enzymes having improved properties as compared to a naturally occurring wild-type ketoreductase enzyme including the capability of reducing 5-((4S)-2-oxo-4-phenyl (1,3-oxazolidin-3-yl))-1-(4-fluorophenyl) pentane-1,5-dione to (4S)-3-[(5S)-5-(4-fluorophenyl)-5-hydroxypentanoyl]-4-phenyl-1,3-oxazolidin-2-one. Also provided are polynucleotides encoding the engineered ketoreductase enzymes, host cells capable of expressing the engineered ketoreductase enzymes, and methods of using the engineered ketoreductase enzymes to synthesize the intermediate (4S)-3-[(5S)-5-(4-fluorophenyl)-5-hydroxypentanoyl]-4-phenyl-1,3-oxazolidin-2-one in a process for making Ezetimibe.